SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Laurus Labs

BSE: 540222 30 Apr 2025
Healthcare
₹ 616.15
Laurus Labs Limited specializes in Pharmaceuticals within the Healthcare sector.

Laurus Labs - Share Price & Details

Market Cap
₹33,299
High /Low
661.0 / 385.0
Stock P/E
92.9
Book Value
₹82.9
Dividend Yield
0.19
ROCE
9.96
ROE
₹8.35
Face Value
2.0
PEG Ratio
13.3
EVEBITDA
₹31.8
Debt
2,764
CMP / FCF
1,765
Debt to equity
₹0.62
NP Ann
358
High price all time
724.0
Piotroski score
₹7.0
Graham Number
111.0
No. Eq. Shares
53.9
Net CF
₹-40.8
Net profit
358
Price to book value
7.44
Interest Coverage
₹3.24
Low price all time
59.0
Industry PE
30.0
Reserves
₹4,365
Free Cash Flow
₹60.5

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic0.700.190.61NA3.1123.9
Triochem Products Ltd.,4.590.88NA3.600
Laurus Labs Limited14,244.70929.4014,150.501.7133,29992.9
Global Health Limited9594.61428.589434.365.323162662.3
SUVEN PHARMACEUTICALS LIMITED3228.6832.93071.53.2328980104.0

Peer Comparison Chart


About Laurus Labs

Laurus Labs Limited, with Security Code 540222, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Laurus Labs Stock Declines 3.5% on January 15, Underperforming Sector by 3.2%

(16 Jan 2025)
Laurus Labs, a prominent player in the pharmaceuticals and drugs sector, experienced a decline of 3.5% on January 15, 2025.
Read more →

I-T Dept imposes Rs 3.86 cr penalty on Laurus Labs for disallowed deduction

(15 Jan 2025)
Laurus Labs further clarified that the penalty proceedings would not have any financial impact on the company.
Read more →

Laurus Labs Limited's (NSE:LAURUSLABS) P/S Is On The Mark

(02 Jan 2025)
When close to half the companies in the Pharmaceuticals industry in India have price-to-sales ratios (or "P/S") below...
Read more →

Laurus Labs Ltd gains for fifth session

(02 Jan 2025)
Laurus Labs Ltd is quoting at Rs 590.25, up 0.61% on the day as on 12:44 IST on the NSE. The stock is up 36.3% in last one year as compared to a 9.49% gain
Read more →

Buy Laurus Labs, target price Rs 710: Bajaj Broking

(27 Dec 2024)
Bajaj Broking recommends buying Laurus Labs with a target price of Rs 710. The current price is Rs 565.4. Laurus Labs expects significant...
Read more →

Stocks in news: UltraTech, RIL, TCS, Vedanta, NTPC Green, IOC, Auro Pharma & Laurus Labs

(24 Dec 2024)
Stocks including UltraTech Cement, Reliance Industries, Tata Consultancy Services, NTPC Green, Indian Oil, Aurobindo Pharma, Laurus Labs and...
Read more →